Seroprevalence of HBsAg in Patients with Chronic Liver Disease and Hepatocellular Carcinoma at the Earliest Endpoint of treatment: A Cross-Sectional Study Seroprevalence of HBsAg in Patients with Chronic Liver Disease and Hepatocellular Carcinoma
Zenodo (CERN European Organization for Nuclear Research)